Skip to content

Intellect Neurosciences, Inc.: 10-Q filed 2014-02-14

What Intellect Neurosciences, Inc. reported in its quarterly report filed 2014-02-14 (fiscal Q2 2014): 22 published measures, 78 facts as tagged in accession 0001144204-14-009427.

This filing

Form
10-Q (quarterly report)
Filed
2014-02-14
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-009427 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Intellect Neurosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-315,400USD
At 2013-06-309,853USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3119,303,329USD
At 2013-06-3013,558,279USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-19,297,929USD
At 2013-06-30-13,548,426USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-31685USD
At 2013-06-305,138USD
At 2012-12-3111,506USD
At 2012-06-302,307USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-2,129,315USD92
2013-07-01 to 2013-12-31-6,226,334USD184
2005-04-25 to 2013-12-31-88,468,300USD3173
2012-10-01 to 2012-12-31-136,924USD92
2012-07-01 to 2012-12-31-283,193USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-07-01 to 2013-12-310USD184
2005-04-25 to 2013-12-311,059,699USD3173
2012-07-01 to 2012-12-310USD184

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-10-01 to 2013-12-31306,036,582shares92
2013-07-01 to 2013-12-31268,069,713shares184
2012-10-01 to 2012-12-31107,990,020shares92
2012-07-01 to 2012-12-31105,655,781shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-10-01 to 2013-12-31306,036,582shares92
2013-07-01 to 2013-12-31268,069,713shares184
2012-10-01 to 2012-12-31107,990,020shares92
2012-07-01 to 2012-12-31105,655,781shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-0.01USD/shares92
2013-07-01 to 2013-12-31-0.02USD/shares184
2012-10-01 to 2012-12-310USD/shares92
2012-07-01 to 2012-12-310USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-0.01USD/shares92
2013-07-01 to 2013-12-31-0.01USD/shares184
2012-10-01 to 2012-12-310USD/shares92
2012-07-01 to 2012-12-310USD/shares184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-348,466USD92
2013-07-01 to 2013-12-31-715,068USD184
2005-04-25 to 2013-12-31-50,208,675USD3173
2012-10-01 to 2012-12-31-402,159USD92
2012-07-01 to 2012-12-31-949,487USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-31685USD
At 2013-06-305,138USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-10-01 to 2013-12-311,791,030USD92
2013-07-01 to 2013-12-315,527,908USD184
2005-04-25 to 2013-12-3175,462,772USD3173
2012-10-01 to 2012-12-311,048,453USD92
2012-07-01 to 2012-12-311,926,175USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3117,508,186USD
At 2013-06-3012,326,542USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-3158,921USD92
2013-07-01 to 2013-12-3168,400USD184
2005-04-25 to 2013-12-3114,723,489USD3173
2012-10-01 to 2012-12-3116,062USD92
2012-07-01 to 2012-12-31183,982USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31317,715,676shares
At 2013-06-30209,015,899shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-3170,502,631USD
At 2013-06-3070,134,497USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-2,129,315USD92
2013-07-01 to 2013-12-31-6,226,334USD184
2005-04-25 to 2013-12-31-90,118,300USD3173
2012-10-01 to 2012-12-31-136,924USD92
2012-07-01 to 2012-12-31-283,193USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31289,545USD92
2013-07-01 to 2013-12-31646,668USD184
2005-04-25 to 2013-12-3146,001,853USD3173
2012-10-01 to 2012-12-31386,097USD92
2012-07-01 to 2012-12-31765,505USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,780,849USD92
2013-07-01 to 2013-12-31-5,511,266USD184
2005-04-25 to 2013-12-31-38,259,625USD3173
2012-10-01 to 2012-12-31265,235USD92
2012-07-01 to 2012-12-31666,294USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2013-07-01 to 2013-12-310USD184
2005-04-25 to 2013-12-31145,115USD3173
2012-07-01 to 2012-12-310USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-07-01 to 2013-12-310USD184
2005-04-25 to 2013-12-311,761,353USD3173
2012-07-01 to 2012-12-310USD184

Inspect the source

Entity
Intellect Neurosciences, Inc. / CIK 0001337905
Captured
SEC response SHA-256
236c93f4b109a1d0e3c5b32c838cb7ed4bcea14b1d8d77aad2aa400fa8dd42ce

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001337905.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))